Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02410382 · ClinicalTrials.gov registry record · Phase 2

Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer

A Phase 2 study, sponsored by University of Arizona.

Terminated
Registry status
Phase 2
Development phase
79
Enrollment target

NCT02410382: Clinical Trial Phase 2 study, sponsored by University of Arizona.

NCT02410382 is a Phase 2 study that was terminated before completion, run by University of Arizona. The registered enrollment target is 79 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02410382, a Phase 2 study, was terminated before completion, sponsored by University of Arizona.

TERMINATED
Registry status
Phase 2
Development phase
79 participants
Enrollment target

Study Summary

This study will look at how dexamethasone and placebo influence radiation fatigue, quality of life and number of treatment days missed during radiation therapy or radiation therapy and chemotherapy for cancer.

Primary Outcome

To compare the effects of dexamethasone and placebo on radiation fatigue using validated measures

Interventions

  • DRUG Placebo
  • DRUG Dexamethasone

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2014-08-27
Est. Completion 2018-02-16
Phase Phase 2
University of Arizona

349 total trials

Why NCT02410382 stopped before completion

NCT02410382 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (41% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02410382 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02410382 about?

NCT02410382 is a clinical study titled "Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer". This study will look at how dexamethasone and placebo influence radiation fatigue, quality of life and number of treatment days missed during radiation therapy or radiation therapy and chemotherapy for cancer.

What is the current status of trial NCT02410382?

This trial is currently terminated. It is a Phase 2 study. The enrollment target is 79 participants. The study started on 2014-08-27. Estimated completion is 2018-02-16.

What interventions are being tested in trial NCT02410382?

The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG).

Who is sponsoring clinical trial NCT02410382?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02410382's enrollment target sits among peer trials

79 884th of 2000 higher than 1,117 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05798897 · 79 participants · Phase 1

    Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • NCT06042439 · 79 participants · NA

    AM vs PM Exercise Training

  • NCT06223555 · 79 participants · NA

    Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02410382, the US trial registry maintained by the National Library of Medicine. NCT02410382 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.